about
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursorsLight and electron microscopy characteristics of the muscle of patients with SURF1 gene mutations associated with Leigh diseaseEctopic virilising adrenocortical tumour in the spinal region in an 8 year-old boy: a case report and review of the literatureSubgroup-specific alternative splicing in medulloblastomaSubgroup-specific structural variation across 1,000 medulloblastoma genomesGiant cerebellar cavernous malformation in 4-month-old boy. Case report and review of the literature.Epilepsy in newborns with tuberous sclerosis complex.MR imaging, apparent diffusion coefficient and histopathological features of desmoplastic infantile tumors-own experience and review of the literature.Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a PolisIdentification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization.Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.Apoptotic proteins and markers of differentiation in childhood pineal parenchymal tumors: relationships and prognostic value.Epigenomic alterations define lethal CIMP-positive ependymomas of infancyCongenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaContrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligaseSpinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in HippocampusThe germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.Pathogenesis of medulloblastoma and current treatment outlook.Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisTERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.Cytogenetic prognostication within medulloblastoma subgroups.Atypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease.Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas.Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.Intertumoral Heterogeneity within Medulloblastoma Subgroups.ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients.Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn's disease.Heterogeneity of histopathological presentation of pilocytic astrocytoma - diagnostic pitfalls. A review.Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis.The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease.Lack of Impact of Presence of Positive C4d Staining in Capillaries in Myocardial Biopsies on Long-term Survival of Heart Transplant Patients.
P50
Q24629817-CD731E33-E246-401A-B3F2-AFCDBB7839BAQ24648969-739AA9C0-4D58-4E79-A6AF-E9381E73E3EAQ26795446-F2F0CB85-DE5D-4BFC-ABEC-E692459E52F7Q28260516-CD6FD466-16FA-42AD-BD64-73CB585F3C79Q28271811-EE486539-7BCB-44C4-92FA-29C1F3E004B3Q30724637-9FFFD531-CDA8-4159-9EB4-3A0AFE5ADD0EQ30836801-CCB100D5-1203-4D27-93FB-6EAA82EFB295Q30871020-8C8EBFC5-F763-4E10-8F8E-D99015A565ECQ30976093-02B72D70-22ED-4F32-8648-3B2F3EDDA892Q33200964-D35653FD-CBD6-44EF-B758-359ECAC09239Q33366431-550A6EA7-B84B-4132-BCA3-D17EC1679E28Q33496177-33408221-244D-4D9D-A6D9-9EC0546E7911Q34240198-808C3319-2EB8-4FD2-B52A-496E5AD4294EQ34468812-1A720EFB-D4D5-408D-A22F-4DCAF46FD6C3Q34515911-5650495C-C0DD-440D-88A9-CCF2A6A37888Q34979270-386169BE-196B-49D2-9D30-A6B774207E02Q35630417-0B4E54BB-1FB7-454F-BDB6-FC37979F9362Q35899265-2C97A389-BB8C-4451-8BE1-11986C3856F5Q35958168-576FB6EF-FCA6-4F5D-B5F4-029DED90C704Q35960250-9AD37E91-6553-4225-A202-0895400C9C17Q36070798-619ECB3D-0B6F-4608-839B-30343DCB71A1Q36099036-D3BA4150-C526-426A-A5C7-0B3E34578B1AQ36334648-C1E83F5C-A5A0-4E91-A919-7BF22C7D2088Q36545074-6B71E86A-76C0-4381-B286-8C7C36C3BCABQ36646948-AB4B236D-169E-4D32-A852-B1BA6237DD12Q36929844-E7B96620-FF28-4AD6-A4D5-D0B73861A6CBQ37004219-70E301BE-8A6B-4712-A677-C7B4AD2143BAQ37130238-9D49A909-8630-4336-AA1A-7AE2AF4A04EAQ37316068-7BCB0B03-DAE4-4780-9C9E-B4EDF20ED77AQ37627692-046ED066-346B-4E94-B1C5-C93FAE067E4EQ37821086-8BFF8E30-AF1F-47EA-819E-A3A12EA62319Q38332213-86A95E53-AC88-453E-A6A5-5D2657FFB72CQ38386723-D5E066E6-F5F8-4AF2-964A-18BC5A3C36DAQ38671456-1395F59F-D5E7-4C17-93CD-5EEB5D6D618AQ38879941-847FC638-24D3-4CB7-BB62-B6838B20A4E0Q38880732-CAE134D7-8801-4F59-9792-7654EDB68F46Q38986344-01353DB6-45AA-42ED-B6F9-4389A5AC95B9Q39254554-9630CBBE-AACB-433D-A626-D35B40590FD9Q39314651-8BF75382-7D43-4CFB-B65B-2854E6C3A843Q39518462-99413AD0-365F-4506-9813-56C4937A2498
P50
description
researcher ORCID ID = 0000-0001-8318-5781
@en
wetenschapper
@nl
name
Wiesława Grajkowska
@ast
Wiesława Grajkowska
@en
Wiesława Grajkowska
@es
Wiesława Grajkowska
@nl
Wiesława Grajkowska
@pl
type
label
Wiesława Grajkowska
@ast
Wiesława Grajkowska
@en
Wiesława Grajkowska
@es
Wiesława Grajkowska
@nl
Wiesława Grajkowska
@pl
altLabel
Wiesława Anna Grajkowska
@pl
prefLabel
Wiesława Grajkowska
@ast
Wiesława Grajkowska
@en
Wiesława Grajkowska
@es
Wiesława Grajkowska
@nl
Wiesława Grajkowska
@pl
P106
P1153
15044394300
P214
168147266648235480847
P31
P3124
P496
0000-0001-8318-5781
P7859
viaf-168147266648235480847